Gilead Sciences on Monday released its pricing plan for remdesivir, its coronavirus drug that was the first treatment to show results in shortening the duration of the disease, after weeks of
and debate over how the pharma giant should balance the drug’s potential significance to public health with its own profits and responsibilities to shareholders.In a statement on Monday, Gilead said it will charge governments in the developed world—including programs like Medicare in the U.S.—$2,340 for a typical five-day treatment course, or $390 per vial for six vials.
Private insurance companies in the United States will pay more: $3,120 for a typical course of treatment, or $520 per vial. Countries in the developing world, where Gilead has licensed the drug to generic manufacturers, will pay significantly less. Gilead estimates that the drug will reduce hospital costs by $12,000 per patient based on data showing that Covid-19 patients taking remdesivir were discharged from the hospital four days earlier than those undergoing a standard treatment plan. its entire remdesivir stockpile of 1.5 million doses to the U.S. government to allocate on an as-needed basis through the end of June.
too much, how much gov money used in this reaserch terrible. should be 50 bucks max
'there is no playbook for how to price a new medicine in a pandemic.' yes. there is. make it fucking free.
Trump should pay for Remdesivir for all Americans, like he promised insurance companies would do. Just like he should pay for the wall. Instead Americans will pay for his mistakes yet again.
Me and you soon🤲🏾🙏🏾
Salam Kindly & Humble Requesting if anyone of u having Any Elec.Job please do help this person he knows CCTV installation and all kind of Electrical Technician Jobs,He is very Needy and belong to V-Poor family Muhammad Farooq Sab C-No:03172278060 C-No:0311 2210890
$3,120
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gilead prices COVID-19 drug candidate remdesivir at $2,340 per patient in U.S.Gilead Sciences Inc has priced its COVID-19 drug candidate remdesivir at $390 per vial for the United States and governments of other developed countries, it said on Monday, setting the price of a five-day course at $2,340 per patient. See? It's all about MONEY gotta make a buck while people die
Source: Reuters - 🏆 2. / 97 Read more »
Coronavirus updates: More states close bars, slow reopening plans; Gilead Sciences sets price for remdesivir treatmentsMore states were slowing reopening plans Monday amid a national boom in coronavirus cases, although one Arizona mayor is unmoved by the ominous trend in his state. Ok I do not want to sleep alone What can you say about people who never learn? You have to learn from others mistakes because you'll never live long enough to make them all yourself.
Source: USATODAY - 🏆 100. / 63 Read more »
Coronavirus live updates: Gilead announces remdesivir pricing; U.K. eyes big investments to rebuild economyThe coronavirus has infected more than 10.15 million people around the world as of Monday, killing at least 502,048 people. Between unmarked black delivery vans and the company name Gilead, I may have to give up watching HandmaidsOnHulu or else start looking to relocate to Canada. weebiejeebies HandmaidsTale Gilead pharmaceutical
Source: CNBC - 🏆 12. / 72 Read more »
Coronavirus live updates: Gilead announces remdesivir pricing; U.K. eyes big investments to rebuild economyThe coronavirus has infected more than 10.15 million people around the world as of Monday, killing at least 502,048 people. Between unmarked black delivery vans and the company name Gilead, I may have to give up watching HandmaidsOnHulu or else start looking to relocate to Canada. weebiejeebies HandmaidsTale Gilead pharmaceutical
Source: CNBC - 🏆 12. / 72 Read more »
Gilead prices COVID-19 drug candidate remdesivir at $2,340 per patient in U.S.Gilead Sciences Inc has priced its COVID-19 drug candidate remdesivir at $390 per vial for the United States and governments of other developed countries, it said on Monday, setting the price of a five-day course at $2,340 per patient. See? It's all about MONEY gotta make a buck while people die
Source: Reuters - 🏆 2. / 97 Read more »
Coronavirus updates: More states close bars, slow reopening plans; Gilead Sciences sets price for remdesivir treatmentsMore states were slowing reopening plans Monday amid a national boom in coronavirus cases, although one Arizona mayor is unmoved by the ominous trend in his state. Ok I do not want to sleep alone What can you say about people who never learn? You have to learn from others mistakes because you'll never live long enough to make them all yourself.
Source: USATODAY - 🏆 100. / 63 Read more »